|
|
Volumn 121, Issue 3, 2001, Pages 162-165
|
|
Erythropoietin for autologous blood donation in total hip arthroplasty patients
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMINO ACID;
GLYCOPROTEIN;
HEMOGLOBIN;
IRON;
LOW MOLECULAR WEIGHT HEPARIN;
PLACEBO;
RECOMBINANT ERYTHROPOIETIN;
ADULT;
AGED;
ARTICLE;
BLOOD AUTOTRANSFUSION;
BLOOD DONOR;
BLOOD SAMPLING;
BONE MARROW;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOSE RESPONSE;
DRUG EFFICACY;
ERYTHROPOIESIS;
FEMALE;
HEMOGLOBIN DETERMINATION;
HUMAN;
MALE;
PEROPERATIVE CARE;
POSTOPERATIVE CARE;
PREOPERATIVE CARE;
PREOPERATIVE EVALUATION;
PRIORITY JOURNAL;
PROSPECTIVE STUDY;
RANDOMIZED CONTROLLED TRIAL;
RETICULOCYTE COUNT;
TOTAL HIP PROSTHESIS;
TREATMENT OUTCOME;
TREATMENT PLANNING;
ADULT;
AGED;
ARTHROPLASTY, REPLACEMENT, HIP;
BLOOD CELL COUNT;
BLOOD TRANSFUSION, AUTOLOGOUS;
COMBINED MODALITY THERAPY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
ERYTHROPOIETIN, RECOMBINANT;
FEMALE;
FOLLOW-UP STUDIES;
HEMOGLOBINS;
HUMANS;
MALE;
MIDDLE AGED;
POSTOPERATIVE PERIOD;
PREOPERATIVE CARE;
PROSPECTIVE STUDIES;
REFERENCE VALUES;
RISK ASSESSMENT;
TREATMENT OUTCOME;
|
|
EID: 0035108528
PISSN: 09368051
EISSN: None
Source Type: Journal
DOI: 10.1007/s004020000197 Document Type: Article |
|
Times cited : (11)
|
|
References (15)
|
